Authors: STRICKLER HD SCHIFFMAN MH SHAH KV RABKIN CS SCHILLER JT WACHOLDER S CLAYMAN B VISCIDI RP

Citation: Hd. Strickler et al., A SURVEY OF HUMAN-PAPILLOMAVIRUS-16 ANTIBODIES IN PATIENTS WITH EPITHELIAL CANCERS, European journal of cancer prevention, 7(4), 1998, pp. 305-313

Authors: LAMBERT JS VISCIDI R WALKER MC CLAYMAN B WINGET M WOLFF M SCHWARTZ DH

Citation: Js. Lambert et al., ANTIBODY TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 (HIV-1) GP160 IN MUCOSAL SPECIMENS OF ASYMPTOMATIC HIV-1-INFECTED VOLUNTEERS PARENTERALLY IMMUNIZED WITH AN EXPERIMENTAL RECOMBINANT HIV-1 IIIB GP160 VACCINE, Clinical and diagnostic laboratory immunology, 4(3), 1997, pp. 302-308

Authors: VISCIDI RP KOTLOFF KL CLAYMAN B RUSS K SHAPIRO S SHAH KV

Citation: Rp. Viscidi et al., PREVALENCE OF ANTIBODIES TO HUMAN PAPILLOMAVIRUS (HPV) TYPE-16 VIRUS-LIKE PARTICLES IN RELATION TO CERVICAL HPV INFECTION AMONG COLLEGE-WOMEN, Clinical and diagnostic laboratory immunology, 4(2), 1997, pp. 122-126

Authors: FUNKHOUSER A CLEMENTS ML SLOME S CLAYMAN B VISCIDI R

Citation: A. Funkhouser et al., ANTIBODIES TO RECOMBINANT GP160 IN MUCOSAL SECRETIONS AND SERA OF PERSONS INFECTED WITH HIV-1 AND SERONEGATIVE VACCINE RECIPIENTS, AIDS research and human retroviruses, 9(7), 1993, pp. 627-632